관련 약점
CWE-ID
약점 이름
출처
CWE-287
Improper Authentication When an actor claims to have a given identity, the product does not prove or insufficiently proves that the claim is correct.
메트릭
메트릭
점수
심각도
CVSS 벡터
출처
V2
7.6
AV:N/AC:H/Au:N/C:C/I:C/A:C
nvd@nist.gov
EPSS
EPSS는 취약점이 악용될 가능성을 예측하는 점수 모델입니다.
EPSS 점수
EPSS 모델은 0과 1(0~100%) 사이의 확률 점수를 생성합니다. 점수가 높을수록 취약점이 악용될 가능성이 높습니다.
날짜 EPSS V0 EPSS V1 EPSS V2 (> 2022-02-04) EPSS V3 (> 2025-03-07) EPSS V4 (> 2025-03-17) 2022-02-06 – – 1.06% – – 2022-02-13 – – 1.06% – – 2022-03-20 – – 1.06% – – 2022-04-03 – – 1.06% – – 2022-04-10 – – 1.06% – – 2022-07-03 – – 1.06% – – 2022-09-25 – – 1.06% – – 2023-02-19 – – 1.06% – – 2023-03-12 – – – 0.38% – 2023-08-06 – – – 0.42% – 2023-11-12 – – – 0.4% – 2023-12-03 – – – 0.4% – 2023-12-10 – – – 0.4% – 2024-02-11 – – – 0.39% – 2024-02-25 – – – 0.39% – 2024-06-02 – – – 0.39% – 2024-06-02 – – – 0.39% – 2024-08-25 – – – 0.39% – 2024-09-22 – – – 0.39% – 2024-09-29 – – – 0.39% – 2024-12-22 – – – 0.38% – 2025-01-19 – – – 0.38% – 2025-03-18 – – – – 1.14% 2025-03-30 – – – – 1.21% 2025-04-15 – – – – 1.21% 2025-11-18 – – – – 1.21% 2025-11-21 – – – – 1.21% 2025-12-25 – – – – 1.21% 2025-12-28 – – – – 1.21% 2025-12-30 – – – – 0.95% 2026-03-01 – – – – 0.89% 2026-04-05 – – – – 0.89%
EPSS 백분위수
백분위수는 EPSS 점수에 따라 CVE의 순위를 매기는 데 사용됩니다. 예를 들어 EPSS 점수 기준 95번째 백분위수의 CVE는 다른 CVE의 95%보다 악용될 가능성이 높습니다.
날짜 백분위수 2022-02-06 27% 2022-02-13 28% 2022-03-20 29% 2022-04-03 48% 2022-04-10 49% 2022-07-03 5% 2022-09-25 51% 2023-02-19 52% 2023-03-12 69% 2023-08-06 71% 2023-11-12 71% 2023-12-03 7% 2023-12-10 71% 2024-02-11 72% 2024-02-25 73% 2024-06-02 73% 2024-06-02 73% 2024-08-25 74% 2024-09-22 73% 2024-09-29 74% 2024-12-22 73% 2025-01-19 73% 2025-03-18 77% 2025-03-30 77% 2025-04-15 78% 2025-11-18 77% 2025-11-21 78% 2025-12-25 79% 2025-12-28 78% 2025-12-30 76% 2026-03-01 75% 2026-04-05 76%
언급된 제품
구성 0 Emc>>Rsa_netwitness >> Version 까지 (미포함) 9.8.5.19
Emc>>Rsa_security_analytics >> Version 부터 (포함) 10.2 까지 (미포함) 10.2.4
Emc>>Rsa_security_analytics >> Version 부터 (포함) 10.3 까지 (미포함) 10.3.2
참고 자료